Risks of Sales Discontinuation and Product Recalls
First written in FY2018. 2 of 4 entries say "Restated". Latest entry: FY2022-Q2.
Toho Holdings moved to the "Worse" side of this theme in 2021, 2 years before the typical company in this theme (2023).
The whole theme swung hardest in 2025: 13 of 34 companies on the "Worse" side.
10 other companies' latest entry also says "Materialised".
- FY2022-Q2MaterialisedAnnual report
「Quality problems and GMP violations at some generic drug manufacturers led to a succession of product recalls and shipment adjustments.」
It states that product recalls and shipment adjustments actually occurred successively against the backdrop of quality problems and GMP violations involving the products it handles. - FY2020RestatedAnnual report
「If products handled by the Group are withdrawn from sale or recalled because of unexpected side effects, foreign-material contamination or other causes, the Group's results could be affected.」
It continues to identify the risk of discontinued sales and product recalls caused by side effects or foreign-material contamination. - FY2019RestatedAnnual report
「If products handled by the Group are withdrawn from sale or recalled because of unexpected side effects, foreign-material contamination or other causes, the Group's results could be affected.」
It continues to identify discontinued sales and product recalls caused by side effects or foreign-material contamination as risks relating to the products it handles. - FY2018First statedAnnual report
「If products handled by the Group are withdrawn from sale or recalled because of unexpected side effects, foreign-material contamination or other causes, the Group's results could be affected.」
It explicitly identifies discontinued sales and product recalls caused by side effects or foreign-material contamination as new risks relating to the products it handles.